Archives
-
Cationic Lipid-Enriched LNPs for mRNA Vaccines
2026-09-24
This study tested whether adding DOTAP or DODAP to ALC-0315-based lipid nanoparticles could improve intramuscular mRNA expression and vaccine responses. DOTAP produced dose-dependent changes: modest inclusion improved several expression readouts and 10% reduced hepatic expression, but the antibody advantage at 5% was not sustained after boosting.
-
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-09-24
Sulfo-NHS-LC-Biotin provides water-compatible, covalent biotin labeling of accessible primary amines on proteins, peptides, and cell-surface proteins for capture or detection. It is not suitable for intracellular labeling or workflows that require the biotin tag to be reversible.
-
Regorafenib in Cancer Biology: Assays and Insights
2026-09-23
Use Regorafenib (BAY 73-4506) to connect multikinase inhibition with practical viability, migration, invasion, and angiogenesis assays. A recent melanoma study adds an RRM2–ERK/E2F3 hypothesis that researchers can test alongside established kinase readouts.
-
ASB3 E3 Ligase Suppresses Antiviral Immunity via MAVS
2026-09-23
The 2024 reference study identifies ASB3 as an inducible negative regulator of antiviral innate immunity that targets MAVS for K48-linked ubiquitination and proteasomal degradation. Its results connect ASB3 activity with reduced TBK1–IRF3 signaling, impaired type I interferon production, and greater susceptibility to influenza infection, while also providing a framework for examining ASB3–MAVS signaling with complementary detection assays.
-
Alosetron Workflows for Intestinal Signaling
2026-09-22
Alosetron offers a reversible way to isolate 5-HT3 receptor inputs from CDC42-driven epithelial polarity effects in organoids, monolayers, and ex vivo gut models. This guide combines practical dosing, pathway readouts, comparative assay design, and troubleshooting for gastrointestinal motility modulation, epithelial fate, and visceral pain signaling research.
-
MTP Hydrogel for Diabetic Periodontitis
2026-09-22
The reference study develops a hierarchically targeted, ROS-responsive nanoparticle hydrogel that repairs mitochondrial dysfunction in M1 macrophages during diabetic periodontitis. Its combination of tuftsin-directed macrophage targeting, MitoQ delivery, and ROS-triggered local release suppresses inflammasome-associated inflammation and supports periodontal bone regeneration in a diabetic rat model.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Aβ Stress
2026-09-21
The Annexin V-FITC/PI Apoptosis Assay Kit connects phosphatidylserine externalization with membrane integrity to resolve cell-fate transitions during amyloid-beta and oxidative-stress research. This guide explains how to interpret the assay alongside mitochondrial, redox, and viability measurements rather than treating apoptosis as an isolated endpoint.
-
Chicken GSDME Drives RNA Virus-Induced Pyroptosis
2026-09-21
The reference study identifies chicken GSDME as a major pore-forming effector of RNA virus-induced pyroptosis, addressing a longstanding gap caused by the absence of canonical GSDMD in chickens. Using infection, Poly(I:C) stimulation, pathway analysis, and genetic loss-of-function in DF-1 cells, the authors connect MDA5 signaling with caspase activation, GSDME cleavage, pyroptosis, and viral release.
-
Cy5-UTP for RNA Probes in Neuronal Trafficking
2026-09-20
Use Cy5-UTP to convert T7 in vitro transcription into a direct, far-red RNA probe workflow for FISH, neuronal compartment mapping, and dual-color expression arrays. Applied alongside protein and transport assays, it helps distinguish RNA localization from TIA1 granule trafficking and aggregation.
-
Mitochondrial Permeability Transition Pore Assay Kit
2026-09-19
This scenario-based guide explains how Mitochondrial Permeability Transition Pore Assay Kit SKU K2061 supports mitochondrial permeability transition pore detection alongside viability, ROS, and apoptosis workflows. It covers assay principles, protocol parameters, interpretation, controls, and practical vendor-selection criteria for cell death mechanism research.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-18
Turn transient mRNA expression into a sensitive, quantitative readout for delivery studies, gene regulation, viability testing, and imaging. This workflow combines Cap1/poly(A)-optimized reporter RNA with practical formulation controls and recent mRNA-LNP insights.
-
Cy5 maleimide (non-sulfonated) Protocol
2026-09-18
Cy5 maleimide (non-sulfonated), SKU A8139, is a thiol-reactive reagent for fluorescently labeling cysteine-containing peptides and proteins through stable thioether formation. It is appropriate for site-directed protein tracking and fluorescence imaging when an accessible thiol is available, but its low aqueous solubility makes it unsuitable for direct addition as an unformulated aqueous stock or for non-thiol conjugation workflows.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-17
Pair direct Cy5 visualization with luciferase output to separate mRNA uptake from productive translation in one experimental design. This dual-reporter workflow supports mRNA delivery optimization, intracellular trafficking studies, and better-informed comparisons of transient versus more durable expression systems.
-
NDRG1–HIF1α Signaling in Pulmonary Hypertension
2026-09-17
A recent study identifies a feed-forward NDRG1–HIF1α circuit that links hypoxic signaling to metabolic reprogramming and pulmonary vascular remodeling. Its use of complementary cell and mouse models suggests that disrupting this axis, including with Voglibose, may reduce pulmonary hypertension phenotypes, although clinical relevance remains unestablished.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-09-16
The reference study developed a dendritic-cell carrier for directing fluorescently labeled amikacin into Mycobacterium avium granulomas in infected mice. Its findings support cell-mediated localization as a potential way to increase antibiotic exposure at infected tissue while reducing reliance on high systemic doses, although the study primarily established delivery rather than definitive therapeutic superiority.